2005•Unpublished venueRequires access

Nitric Oxide Donors As Anti‐Platelet Agents for Thromboembolic Disorders: Clinical Status and Therapeutic Prognosis

David R. Janero, David S. Garvey

Abstract

This chapter contains sections titled: Introduction Human Platelets, Thromboembolic Disorders, and NO Nitrovasodilators Glyceryl Trinitrate, Nitroglycerin (GTN) Isosorbide Dinitrate (ISDN) and Isosorbide Mononitrate (ISMN) Sodium Nitroprusside (SNP) Oxatriazolium NO Donors Sydnonimines Nitrosothiol NO Donors S-Nitroso-glutathione (GSNO) L-Arginine {S(+)-2-Amino-5-[(aminoiminomethyl)amino]pentanoic acid} (L-arg) NCX-4016 [2-Acetoxybenzoate 2-(1-nitroxy-methyl)-phenyl ester] Conclusion and Future Prospects

About this research paper

What this paper is about

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Isosorbide dinitrate, Sodium nitroprusside, Nitric oxide, Pharmacology, Medicine, Platelet, Arginine, Amino acid